Related Experiment Videos
Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide
U H Ehling1, A Neuhäuser-Klaus
1GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH, Institut für Säugetiergenetik, Neuherberg, Oberschleissheim, Germany.
Abstract:
Trophosphamide induced dominant lethal and specific-locus mutations in spermatozoa and spermatids of mice. The induction pattern of specific-locus and dominant lethal mutations shows two maxima in the mating intervals 1-4 and 9-16 days post treatment. The nature of induced mutations is suggested to be intergenic.
Insights
Trophosphamide causes genetic mutations in mouse sperm, with peak effects observed 1-4 and 9-16 days after treatment. These mutations are likely intergenic, impacting DNA at specific gene locations.
Area of Science:
- Genetics
- Toxicology
- Reproductive Biology
Background:
- Trophosphamide is a chemotherapeutic agent.
- Understanding its genotoxic effects is crucial for risk assessment.
- Spermatozoa and spermatids are key targets for mutagenicity studies.
Purpose of the Study:
- To investigate the mutagenic potential of Trophosphamide.
- To determine the mutation induction pattern in mouse germ cells.
- To characterize the nature of Trophosphamide-induced mutations.
Main Methods:
- Mice were treated with Trophosphamide.
- Dominant lethal mutations were assessed through mating trials.
- Specific-locus mutations were analyzed post-treatment.
- Mutation induction patterns were mapped across different mating intervals.
Main Results:
- Trophosphamide induced both dominant lethal and specific-locus mutations.
- Two distinct peaks in mutation induction were observed at 1-4 and 9-16 days post-treatment.
- The data suggests that induced mutations are primarily intergenic.
Conclusions:
- Trophosphamide exhibits significant genotoxicity in mouse germ cells.
- The temporal pattern of mutation induction provides insights into spermatogenesis.
- Intergenic mutations are the likely outcome of Trophosphamide exposure.